510(k) K892526
K892526 is an FDA 510(k) premarket notification submitted by Atlantic Antibodies for the device "SPQ TM TEST SYSTEM II FOR CRP". The FDA issued a decision of Substantially Equivalent on May 9, 1989. The device falls under product code DCK (C-Reactive Protein, Antigen, Antiserum, And Control), a Class II device regulated under 21 CFR 866.5270. Atlantic Antibodies has at least 10 other 510(k) clearances on record.
Clearance Details
- Decision
- SESE (Substantially Equivalent)
- Decision Date
- May 9, 1989
- Date Received
- April 11, 1989
- Clearance Type
- Traditional
- Expedited Review
- No
- Third Party Review
- No
Device Classification
- Device Name
- C-Reactive Protein, Antigen, Antiserum, And Control
- Device Class
- Class II
- Regulation Number
- 866.5270
- Review Panel
- IM
- Submission Type